aortic aneurysm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age = 18 years old, no gender limit; 2) Patients who need endovascular repair of thoracic/abdominal aortic disease; 3) Patients who can understand the purpose of the trial, are willing to participate, and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1) Patients with aortic aneurysm rupture or impending rupture; 2) Patients with mycotic or infectious aortic aneurysm; 3) Patients with connective tissue diseases, such as Marfan syndrome, Ehlers-Danlos syndrome, or Behcet's disease; 4) Patients with a history of unstable angina pectoris within the past 6 months (gradually worsening angina symptoms, newly developed angina at rest or during sleep, or prolonged duration of angina); 5) Patients with transient ischemic attack (TIA) or ischemic stroke within the past 3 months; 6) Patients who have undergone aortic surgery or endovascular surgery; 7) Patients with contraindications to anticoagulation; 8) Active infection; 9) Patients with contraindications to contrast agents; 10) Patients with impaired liver and kidney function; 11) Patients who have participated in other pre-market studies or received experimental drugs or devices and have not reached the primary endpoint; 12) Female patients who are pregnant or lactating, or female patients of fertile age with positive pregnancy test results; 13) Other situations deemed unsuitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| technical success;device-related major adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical success;fluoroscopy time;radiation exposure of doctors;contrast medium volume;operation time; | — |
Countries
China
Contacts
Department of Vascular Surgery, Shanghai Changhai Hospital